← ANALYSTS · TIPRANKS
Michael Ulz · Morgan Stanley
Hits
43%
170 of 398 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+0.9%
Over a year after the rating, TipRanks’ measure
Our companies rated now
16
Buy / hold / sell: 10 / 6 / 0
Upside of the analyst’s targets
+302.1%
Average over 16 current targets, to the last price
The market’s answer to the ratings
−3.7%
Day-0 move against SPY in the rating’s direction, average over 5 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 12on TipRanks 17:45 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $137 → $152+10.9% | +89.7% | −7.5%next day +1.5% | ↗ |
| Oct 9on TipRanks Oct 11 19:06 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Hold | $300 | +29.4% | +3.0%next day −2.4% · 5 days +1.6% | ↗ |
| Oct 7on TipRanks 06:15 | RCKTIWMRocket Pharmaceuticals · $259M | Reiterated | Hold | $5.00 | +129.4% | +2.5%next day +4.2% · 5 days −11.8% | ↗ |
| Oct 6on TipRanks Oct 7 06:15 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $95.00 | +277.4% | −3.6%next day +0.8% · 5 days −6.0% | ↗ |
| Oct 5on TipRanks 08:35 | GUTSFractyl Health, Inc. · $777M | Assigned | Hold | $24.00 | +1,448.4% | −7.2%next day −0.3% · 5 days −3.7% | ↗ |
| Sep 28on TipRanks Sep 29 07:09 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $137 | +71.0% | −1.2%next day −0.3% · 5 days −8.6% | ↗ |
| Sep 22on TipRanks 10:55 | VKTXViking Therapeutics · $3.4B | Reiterated | Buy | $95.00 | +277.4% | +35.7%next day +2.7% · 5 days −20.9% | ↗ |
| Sep 11on TipRanks Sep 12 13:35 | ALNYQQQAlnylam Pharma · $31.3B | Reiterated | Hold | $300 | +29.4% | −0.4%next day +1.0% · 5 days −3.6% | ↗ |
| Sep 9on TipRanks 07:55 | DYNIWMDyne Therapeutics · $2.9B | Reiterated | Buy | $45.00 → $36.00−20.0% | +152.6% | −5.0%next day −3.4% · 5 days −8.7% | ↗ |
| Sep 9on TipRanks Sep 8 07:55 | IONSIonis Pharmaceuticals · $7.0B | Assigned | Buy | $104 | +142.2% | −1.8%next day −0.8% · 5 days −15.6% | ↗ |
| Aug 31on TipRanks Sep 1 07:30 | ARWRArrowhead Pharmaceuticals · $8.2B | Reiterated | Buy | $120 | +114.7% | −2.7%next day +1.1% · 5 days +3.4% | ↗ |
| Aug 24on TipRanks Aug 25 07:13 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Reiterated | Buy | $150 | +74.1% | +1.6%next day +1.4% · 5 days −5.2% | ↗ |
| Aug 17on TipRanks Aug 14 08:35 | CABAIWMCabaletta Bio · $275M | Assigned | Buy | $13.00 | +822.0% | +1.7%next day +5.6% · 5 days +15.2% | ↗ |
| Aug 12on TipRanks 08:20 | KYTXIWMKyverna Therapeutics, Inc. · $369M | Assigned | Buy | $33.00 | +482.0% | +0.1%next day −0.3% · 5 days +10.6% | ↗ |
| Aug 12on TipRanks Aug 11 09:45 | RCKTIWMRocket Pharmaceuticals · $259M | Assigned | Hold | $5.00 | +129.4% | −3.5%next day −2.8% · 5 days −4.2% | ↗ |
| Aug 7on TipRanks 09:35 | BIOAIWMBioAge Labs, Inc. · $249M | Reiterated | Hold | $23.00 → $20.00−13.0% | +313.2% | +3.4%next day −2.3% · 5 days −10.0% | ↗ |
| Aug 7on TipRanks 08:21 | ZNTLIWMZentalis Pharmaceuticals · $212M | Reiterated | Hold | $4.00 → $5.00+25.0% | +134.7% | −16.2%next day −1.6% · 5 days −16.0% | ↗ |
| Aug 6on TipRanks 07:11 | VIRIWMVir Biotechnology · $1.8B | Assigned | Buy | $27.00 → $25.00−7.4% | +151.0% | −3.6%next day 0.0% · 5 days +1.5% | ↗ |
| Aug 6on TipRanks 07:10 | SRPTIWMSarepta Therapeutics · $1.9B | Assigned | Hold | $25.00 | +46.2% | +5.5%next day −0.6% · 5 days +8.6% | ↗ |
| Jun 3on TipRanks Jun 4 06:50 | TNYATenaya Therapeutics · $126M | Reiterated | Buy | $2.00 | +426.3% | +0.1%next day −2.0% · 5 days −7.3% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗